Page 1 | Search Results | Blood Neoplasia | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Phase 2 trial of daratumumab, cyclophosphamide, thalidomide, and dexamethasone in newly diagnosed multiple myeloma

Edvan de Queiroz Crusoé, Joanna Suzana Leal Ribeiro dos Santos, Juliana de Andrade Santos, Herbert Henrique de Melo Santos, Allan de Souza Santos, Larissa Ferreira Lucas, Cristiane Almeida Requião de Pinna, Paula Nogueira Caldas Freire, Adriano Araujo de Jesus, Alessandro de Moura Almeida, Daniela Dourado Dutra, Marcos Fonseca Chaves, Jamile Souza Nicanor, Marco Aurelio Salvino, Maria da Gloria Bomfim Arruda, Vania Hungria

Blood Neoplasia (2025) 2 (3): 100081.

https://doi.org/10.1016/j.bneo.2025.100081

Published: 2025

Includes: Supplemental data

Journal Articles

Ambroxol induces myeloma cell death by inhibiting autophagy

Yutaka Hattori, Hiromu Sugiyama, Yamato Miyashita, Shinsuke Shibata, Taiga Okaue, Yoshinao Matsumoto, Taketo Yamada, Tomofumi Yamamoto, Takashi Yamaguchi, Kohei Yamazaki, Hisako Kunieda, Hideyuki Saya, Maiko Matsushita

Blood Neoplasia (2025) 2 (3): 100100.

https://doi.org/10.1016/j.bneo.2025.100100

Published: 2025

Includes: Supplemental data

Journal Articles

Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experience

Blood Neoplasia (2025) 2 (3): 100103.

https://doi.org/10.1016/j.bneo.2025.100103

Published: 2025

Journal Articles

Magnetic resonance spectroscopy–based detection of response to therapy targeting glutaminolysis in lymphoma

Kavindra Nath, Pradeep K. Gupta, Shengchun Wang, Alexander A. Shestov, Neil Sen, Shilpa Rao, Stepan Orlovskiy, Cosimo Lobello, David Rushmore, Fernando Arias-Mendoza, Johnvesly Basappa, David S. Nelson, Mariusz A. Wasik

Blood Neoplasia (2025) 2 (3): 100105.

https://doi.org/10.1016/j.bneo.2025.100105

Published: 2025

Includes: Supplemental data

Journal Articles

Tumor-associated myeloid cells support murine T-ALL in the central nervous system via integrin signaling

Ryan S. Humphrey, Seohee Nam, Dennis C. Wylie, Lauren I. R. Ehrlich

Blood Neoplasia (2025) 2 (3): 100095.

https://doi.org/10.1016/j.bneo.2025.100095

Published: 2025

Includes: Supplemental data

Journal Articles

Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab

Charles Pei, Zeinab El Boghdadly, Lisa Blackburn, Nidhi Sharma, Naresh Bumma, Abdullah M. Khan, Srinivas Devarakonda, Elvira Umyarova, Don Benson, Ashley Rosko, Francesca Cottini

Blood Neoplasia (2025) 2 (3): 100097.

https://doi.org/10.1016/j.bneo.2025.100097

Published: 2025

Includes: Supplemental data

Journal Articles

Reduced CD20 expression yields inferior survival in patients with B-cell lymphoma treated with CD20×CD3 antibodies

Emil Ramsø Kyvsgaard, Trine Lønbo Grantzau, Mia Dahl Sørensen, Michael Boe Møller, Lene Dissing Sjø, Morten Grauslund, Trine Trab, Linea Cecilie Melchior, Lærke Sloth Andersen, Caroline Riley, Carsten U. Niemann, Jacob Haaber, Thomas Stauffer Larsen, Michael Roost Clausen, Kirsten Grønbæk, Martin Hutchings, Simon Husby

Blood Neoplasia (2025) 2 (3): 100096.

https://doi.org/10.1016/j.bneo.2025.100096

Published: 2025

Includes: Supplemental data

Journal Articles

Retrospective evaluation of R-EPOCH in the frontline treatment of adult patients with PTLD after solid organ transplant

Brian Cuzzo, Maegan Ford, Saagar Jain, Hua-Jay Cherng, Evelyn Orlando, Patrick Gould, Amy Song, Benjamin May, Yuxuan Chen, Govind Bhagat, Andrew H. Lipsky, Barbara Pro, Jennifer E. Amengual

Blood Neoplasia (2025) 2 (2): 100094.

https://doi.org/10.1016/j.bneo.2025.100094

Published: 2025

Journal Articles

Discovery of a novel class NSD2 inhibitor for multiple myeloma with t(4;14) +

Sae Matsuoka, Naoki Osada, Hirokazu Kubota, Ko Kikuzato, Hiroo Koyama, Takeshi Sonoda, Akiko Idei, Minoru Yoshida, Masaki Kikuchi, Takashi Umehara, Chiduru Watanabe, Teruki Honma, Hiroshi Yasui, Sho Ikeda, Naoto Takahashi, Hideki Nakasone, Jiro Kikuchi, Yusuke Furukawa

Blood Neoplasia (2025) 2 (2): 100091.

https://doi.org/10.1016/j.bneo.2025.100091

Published: 2025

Includes: Supplemental data

Journal Articles

Real-world treatment patterns and clinical outcomes in patients with follicular lymphoma: a SEER-Medicare analysis

Dai Chihara, Shibing Yang, Savreet Bains Chawla, Guihua Zhang, Anthony Wang, Junhua Yu, Donald Arnette, Fernando Rivas Navarro, Julie Blaedel, Alex Mutebi

Blood Neoplasia (2025) 2 (2): 100080.

https://doi.org/10.1016/j.bneo.2025.100080

Published: 2025

Includes: Supplemental data

Journal Articles

Short-duration infusion obinutuzumab with venetoclax in chronic lymphocytic leukemia: a prospective observational study

Blood Neoplasia (2025) 2 (2): 100075.

https://doi.org/10.1016/j.bneo.2025.100075

Published: 2025

Journal Articles

Adult leukemia in Florida 2010-2019: diverse, aging population as an indicator for the United States

Ming S. Lee, Rebecca E. Kaiser, Christopher D. Armstrong, David B. Dukenik, Nancy S. Elliott, Raymond R. Balise, Justin M. Watts, Mikkael A. Sekeres, Erin N. Kobetz, Justin Taylor

Blood Neoplasia (2025) 2 (2): 100078.

https://doi.org/10.1016/j.bneo.2025.100078

Published: 2025

Journal Articles

A feedforward loop between ACLY and MYC supports T-ALL progression in vivo

Victoria da Silva-Diz, Amartya Singh, Maya Aleksandrova, Oekyung Kim, Christopher Thai, Olga Lancho, Patricia Renck Nunes, Hayley Affronti, Alexia Martínez de Paz, Steven Z. Josefowicz, Xiaoyang Su, Kathryn E. Wellen, Daniel Herranz

Blood Neoplasia (2025) 2 (2): 100069.

https://doi.org/10.1016/j.bneo.2025.100069

Published: 2025

Includes: Supplemental data

Journal Articles

Single-cell sequencing reveals shared clonal signatures in nonmalignant B and tumor cells in T-prolymphocytic leukemia

Caroline Hesselager, Ingrid Thörn, Millaray Marincevic, Claes Ladenvall, Jonas Almlöf, Sara Löfgren, Simone Weström, Helena Nord, Lesley-Ann Sutton, Lucia Cavelier, Panagiotis Baliakas, Rose-Marie Amini

Blood Neoplasia (2025) 2 (2): 100076.

https://doi.org/10.1016/j.bneo.2025.100076

Published: 2025

Includes: Supplemental data

Journal Articles

Targeting transcription-replication conflicts using G-quadruplexes stabilizers in multiple myeloma

Blood Neoplasia (2025) 2 (2): 100072.

https://doi.org/10.1016/j.bneo.2025.100072

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes of follicular lymphoma with leukemic phase in the modern era: results from a large multicenter study

Blood Neoplasia (2025) 2 (1): 100063.

https://doi.org/10.1016/j.bneo.2024.100063

Published: 2025

Includes: Supplemental data

Journal Articles

Low platelet counts and low CD4/CD8 ratios at apheresis increase the risk of CAR T-cell manufacturing failure in myeloma

Blood Neoplasia (2025) 2 (1): 100051.

https://doi.org/10.1016/j.bneo.2024.100051

Published: 2025

Includes: Supplemental data

Journal Articles

Safety landscape of bispecific antibody therapy in non-Hodgkin lymphoma: a meta-analysis

Rodrigo Fonseca, Alex J. Liu, Blake T. Langlais, Diana Almader-Douglas, Holenarasipur R. Vikram, Talal Hilal

Blood Neoplasia (2025) 2 (1): 100061.

https://doi.org/10.1016/j.bneo.2024.100061

Published: 2025

Includes: Supplemental data

Journal Articles

Population differences in the associations between chromosomal abnormalities and overall survival of multiple myeloma

Bei Wang, Benjamin A. Derman, Madina Sukhanova, Daniel Appelbaum, John Cursio, Wei Zhang, Andrzej Jakubowiak, Brian C.-H. Chiu

Blood Neoplasia (2025) 2 (1): 100065.

https://doi.org/10.1016/j.bneo.2024.100065

Published: 2025

Journal Articles

Aberrant heterochromatin silences immune response genes in chronic lymphocytic leukemia

Olivia M. Depies, Qianqian Guo, Yuan Gao, Sutapa Sinha, Zhenqing Ye, Weiguo Han, Kari G. Rabe, Mingma S. Hoel, Heather C. Darby, Chuanhe Yu, Esteban Braggio, Sameer A. Parikh, Susan L. Slager, Neil E. Kay, Zhiquan Wang

Blood Neoplasia (2025) 2 (1): 100059.

https://doi.org/10.1016/j.bneo.2024.100059

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Date

Availability

Phase 2 trial of daratumumab, cyclophosphamide, thalidomide, and dexamethasone in newly diagnosed multiple myeloma

Ambroxol induces myeloma cell death by inhibiting autophagy

Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experience

Magnetic resonance spectroscopy–based detection of response to therapy targeting glutaminolysis in lymphoma

Tumor-associated myeloid cells support murine T-ALL in the central nervous system via integrin signaling

Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab

Reduced CD20 expression yields inferior survival in patients with B-cell lymphoma treated with CD20×CD3 antibodies

Retrospective evaluation of R-EPOCH in the frontline treatment of adult patients with PTLD after solid organ transplant

Discovery of a novel class NSD2 inhibitor for multiple myeloma with t(4;14) +

Real-world treatment patterns and clinical outcomes in patients with follicular lymphoma: a SEER-Medicare analysis

Short-duration infusion obinutuzumab with venetoclax in chronic lymphocytic leukemia: a prospective observational study

Adult leukemia in Florida 2010-2019: diverse, aging population as an indicator for the United States

A feedforward loop between ACLY and MYC supports T-ALL progression in vivo

Single-cell sequencing reveals shared clonal signatures in nonmalignant B and tumor cells in T-prolymphocytic leukemia

Targeting transcription-replication conflicts using G-quadruplexes stabilizers in multiple myeloma

Outcomes of follicular lymphoma with leukemic phase in the modern era: results from a large multicenter study

Low platelet counts and low CD4/CD8 ratios at apheresis increase the risk of CAR T-cell manufacturing failure in myeloma

Safety landscape of bispecific antibody therapy in non-Hodgkin lymphoma: a meta-analysis

Population differences in the associations between chromosomal abnormalities and overall survival of multiple myeloma

Aberrant heterochromatin silences immune response genes in chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only